SmithKline in radical shake-up

THE DRUGS to Ribena giant SmithKline Beecham yesterday stunned the City with radical plans to cut its workforce by more than a quarter, to focus on its core pharmaceuticals and healthcare businesses.

The company announced the disposal of two underperforming US businesses for over $2bn and the closure or sale of several of its manufacturing plants. The sweeping restructuring will see the departure of around 15,000 of SB's 58,000 employees over the next four years. The measures will land SB with an exceptional charge of over pounds 1bn but the company said they would help to reduce costs and boost profits in the long term.

SB used the announcement to rush out its 1998 results. The figures, released a week earlier than expected, showed a 10 per cent rise in underlying profits to pounds 1.77bn on sales up 7 per cent to pounds 8.3bn.

The chief executive, Jan Leschly, denied suggestions that the shake-up could rekindle a pounds 120bn mega-merger with SB's UK arch-rival Glaxo Wellcome. Talks between the two companies foundered last year after a clash of personalities between Mr Leschly and the Glaxo chairman Sir Richard Sykes. "This has nothing to do with the previous discussions we had on a merger. We think we'll be an independent company now, a stronger company," Mr Leschly said.

He said SB's leaner structure would help to boost earnings by around 13 per cent this year and to produce "mid to high teens growth in 2000 and 2001". Mr Leschly said the restructuring would free up resources for new pharmaceutical products such as the forthcoming blockbuster Avandia, a diabetes drug with expected sales of over $1bn.

Money will also be invested in SB's consumer products, which include Ribena, Lucozade and Aquafresh. SB shares finished 33p higher at 831.5p as dealers welcomed the plans and refused to believe Mr Leschly's denial of merger talks.

SB declined to specify which of its manufacturing plants would close but a spokesman said that there would be few redundancies among UK-based staff. SB employs around 4,000 people at factories at Irvine in Scotland and Crawley and Worthing, both in Sussex. The scale-down in manufacturing and a renegotiation of deals with suppliers will lead to cost savings of pounds 200m a year from 2002. Before then, SB will take a pounds 750m restructuring charge, with pounds 90m already included in this year's accounts.

In a marked shift from the expansionist strategy of the past few years, SB also announced the disposal of two US businesses employing 15,000 people. Clinical Laboratories, a US-based clinical trials unit, was sold to rival Quest Diagnostics for $1bn in cash - well below the $2.3bn paid by SB to acquire the business - and a 29.5 per cent stake in the enlarged group.

DPS, an agency which manages health benefits for 23 million Americans, went to US rival Express Scripts for $700m in cash and a $300m tax benefit. SB said it took a pounds 629m provision for the loss on the DPS operations.The proceeds will go to cutting SB's debt, with gearing set to fall to around 15 per cent from 52 per cent in 1998.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Collections Agent

£14000 - £16000 per annum: Recruitment Genius: This company was established in...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE 40k: SThree: SThree are a global FTSE 250 busi...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + competitive: SThree: SThree are a global FTSE 250 ...

Recruitment Genius: Mortgage Administrator

£20000 - £25000 per annum: Recruitment Genius: We are a vibrant and establishe...

Day In a Page

Migrant crisis: UN official Philippe Douste-Blazy reveals the harrowing sights he encountered among refugees arriving on Lampedusa

‘Can we really just turn away?’

Dead bodies, men drowning, women miscarrying – a senior UN figure on the horrors he has witnessed among migrants arriving on Lampedusa, and urges politicians not to underestimate our caring nature
Nine of Syria and Iraq's 10 world heritage sites are in danger as Isis ravages centuries of history

Nine of Syria and Iraq's 10 world heritage sites are in danger...

... and not just because of Isis vandalism
Girl on a Plane: An exclusive extract of the novelisation inspired by the 1970 Palestinian fighters hijack

Girl on a Plane

An exclusive extract of the novelisation inspired by the 1970 Palestinian fighters hijack
Why Frederick Forsyth's spying days could spell disaster for today's journalists

Why Frederick Forsyth's spying days could spell disaster for today's journalists

The author of 'The Day of the Jackal' has revealed he spied for MI6 while a foreign correspondent
Markus Persson: If being that rich is so bad, why not just give it all away?

That's a bit rich

The billionaire inventor of computer game Minecraft says he is bored, lonely and isolated by his vast wealth. If it’s that bad, says Simon Kelner, why not just give it all away?
Euro 2016: Chris Coleman on course to end half a century of hurt for Wales

Coleman on course to end half a century of hurt for Wales

Wales last qualified for major tournament in 1958 but after several near misses the current crop can book place at Euro 2016 and end all the indifference
Rugby World Cup 2015: The tournament's forgotten XV

Forgotten XV of the rugby World Cup

Now the squads are out, Chris Hewett picks a side of stars who missed the cut
A groundbreaking study of 'Britain's Atlantis' long buried at the bottom of the North Sea could revolutionise how we see our prehistoric past

Britain's Atlantis

Scientific study beneath North Sea could revolutionise how we see the past
The Queen has 'done and said nothing that anybody will remember,' says Starkey

The Queen has 'done and said nothing that anybody will remember'

David Starkey's assessment
Oliver Sacks said his life has been 'an enormous privilege and adventure'

'An enormous privilege and adventure'

Oliver Sacks writing about his life
'Gibraltar is British, and it is going to stay British forever'

'Gibraltar is British, and it is going to stay British forever'

The Rock's Chief Minister hits back at Spanish government's 'lies'
Britain is still addicted to 'dirty coal'

Britain still addicted to 'dirty' coal

Biggest energy suppliers are more dependent on fossil fuel than a decade ago
Orthorexia nervosa: How becoming obsessed with healthy eating can lead to malnutrition

Orthorexia nervosa

How becoming obsessed with healthy eating can lead to malnutrition
Lady Chatterley is not obscene, says TV director

Lady Chatterley’s Lover

Director Jed Mercurio on why DH Lawrence's novel 'is not an obscene story'
Farmers in tropical forests are training ants to kill off bigger pests

Set a pest to catch a pest

Farmers in tropical forests are training ants to kill off bigger pests